Practice Management News

Over a period of 12 years, the number of opioids prescribed per person decreased, whereas the prescribing rate for long-term prescriptions increased, according to findings published in JAMA Network Open.

The rate of physician burnout increased 5% during a 3-year period, according to findings recently published in JAMA Network Open.

The FDA granted Revex fast track designation for the emergency treatment of known or suspected opioid overdose, according to a press release issued by the drug’s manufacturer.

Norman E. “Ned” Sharpless, MD, director of National Cancer Institute, will replace resigning FDA commissioner Scott Gottlieb, MD, according to a tweet from Gottlieb.

A simple waiting room-based tool on an iPad that researchers dubbed the Visit Planner significantly improved visit communication between primary care physicians and patients, according to findings recently published in Annals of Family Medicine.

Receiving opioid prescriptions from both the U.S. Department of Veterans Affairs and Medicare Part D was independently associated with two to three times the odds of unintentional death from an opioid overdose, according to findings published in Annals of Internal Medicine.

As a former adviser to several federal entities, FDA Commissioner Scott Gottlieb, MD was familiar with public service before he assumed his current position in early 2017.

FDA Commissioner Scott Gottlieb, MD, announced his resignation effective 1 month from Tuesday, March 5, according to an HHS press release.

The FDA recently posted a warning letter to CanaRx requesting it immediately stop dispensing “unapproved new drugs” and “misbranded, potentially dangerous drugs” to U.S. consumers.

Representatives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Janssen Pharmaceuticals, Merck, Pfizer and Sanofi voiced support for drug rebate reform, value-based program creation, and increasing transparency, biologics and generics awareness to lower U.S. drug prices at a recent Senate Finance Committee hearing.